A Phase 2 Study of Fedratinib in Patients with MDS/MPN and Chronic Neutrophilic Leukemia von Kuykendall, Andrew T., Pettit, Kristen Marie, Singh, Abhay, Jain, Tania, Sallman, David A, Mo, Qianxing, Lovette, Quan, Zhang, Ling, Chan, Onyee, Walker, Alison R., Xie, Zhuoer, Lancet, Jeffrey, Balasis, Maria, Yun, Seongseok, Padron, Eric, Komrokji, Rami S.

Volltext